PPARGC1A and metabolic dysfunction-associated steatotic liver disease: As a candidate polymorphism for the prevalence of type 2 diabetes mellitus and non-alcoholic fatty liver disease, PGC-1 gene polymorphism is a genetic risk factor for diabetes through its role in stimulating mitochondrial biogenesis and enhancing mitochondrial function.